Candriam Equities L Biotech.I-H EUR Acc/  LU1006082199  /

Fonds
NAV31/07/2024 Chg.+4.7400 Type of yield Investment Focus Investment company
2,269.7400EUR +0.21% reinvestment Equity Candriam